We and others have previously shown that the mitochondrial isoform of phosphoenolpyruvate carboxykinase (PCK2) is the key enzyme in lung cancer cells mediating the conversion of oxaloacetate to PEP in the (truncated) gluconeogenesis pathway [33, 35, 36]. Here, PCK2 is linked to lung carcinoma.